Has Tsz Isabel Wong, NP received payments from drug or device companies?

Yes. Drug and device makers reported $25,181 in general payments to Tsz Isabel Wong, NP across 758 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tsz Isabel Wong, NP did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tsz Isabel Wong, NP come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tsz Isabel Wong, NP

Nurse Practitioner · New York, NYNPI 1144626508

Payments from drug & device makers

$25,181in general payments, 2019–2025

Across 758 payments — averaging $33.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Agios Pharmaceuticals, Inc.$5K
Johnson & Johnson$2K
Astellas Pharma US Inc$1K
Daiichi Sankyo Inc.$1K
Novo Nordisk$943
E.r. Squibb & Sons, L.L.C.$856
plus $14K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Agios Pharmaceuticals, Inc.	21	$5,481
Johnson & Johnson	56	$1,710
Astellas Pharma US Inc	35	$1,021
Daiichi Sankyo Inc.	45	$1,009
Novo Nordisk	30	$943
E.r. Squibb & Sons, L.L.C.	26	$856
Novartis	31	$821
AstraZeneca(2 entities)	37	$813
Merck	35	$786
Eisai Inc.	29	$759
Lilly USA, LLC	32	$729
Rigel Pharmaceuticals, Inc.	16	$540
Gilead	14	$521
Incyte Corporation	12	$507
Bayer	25	$489
Sobi, Inc	21	$457
AbbVie	20	$422
Takeda Pharmaceuticals U.S.A., Inc.	17	$413
Stemline Therapeutics Inc.	17	$400
GSK	17	$361
Beone Medicines USA, Inc.	12	$354
Mirati Therapeutics, Inc.	12	$351
EMD Serono, Inc.	14	$331
Exact Sciences	8	$320
Puma Biotechnology, Inc.	13	$306
Seagen Inc.	10	$298
Pfizer	12	$286
Bristol Myers Squibb	13	$282
Myriad Genetic Laboratories, Inc.	4	$258
Beigene USA, Inc.	10	$254
Regeneron Healthcare Solutions, Inc.	9	$227
Deciphera Pharmaceuticals Inc.	9	$209
Genmab U.S., Inc.	3	$179
Tersera Therapeutics LLC	6	$145
Foundation Medicine, Inc.	5	$136
Neurelis, Inc.	1	$135
Sanofi	5	$132
Amgen	6	$130
AVEO Pharmaceuticals, Inc.	4	$126
Tempus AI, Inc	5	$125
Insmed, Inc.	5	$117
Jazz Pharmaceuticals Inc.	4	$109
Intra-sana Laboratories	1	$100
Exelixis Inc.	1	$99
Sumitomo Pharma America, Inc.	4	$94
Myovant Sciences Inc.	3	$72
Boehringer Ingelheim	3	$68
Ipsen Biopharmaceuticals, Inc	3	$65
Accord Healthcare, Inc.	1	$63
Kowa Pharmaceuticals America, Inc.	4	$59
Azurity Pharmaceuticals, Inc.	2	$59
Recordati_rare_diseases_inc.	2	$52
Novocure Inc.	2	$49
Amarin Pharma, Inc.	2	$48
Secura Bio, Inc.	2	$46
Karyopharm Therapeutics Inc.	2	$46
Array Biopharma Inc	2	$38
Acrotech Biopharma Inc.	2	$37
Taiho Oncology, Inc.	1	$35
Syndax Pharmaceuticals, Inc.	2	$33

How this compares

$25,181 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.

See all nurse practitioner providers in New York →

Medicare billing

Part B allowed, 2024

$60,174

Medicare patients

169

Services billed

5,585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in New York

Patricia McGoldrickNew York$202K
Jodi LogerfoNew York$48K
Aileen FerrickNew York$26K
Chris BustamanteNew York$22K
Mayra PozoNew York$14K
Janet JohnsonNew York$12K
Rachel RankinNew York$10K
Richelle CassellNew York$10K
Michelle DartSyracuse$95K
Susan KreppelWilliamsville$67K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →